This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
| 602 * | Thu, 8/5/2010, 8:30 AM - 10:20 AM | CC-211 (West) |
| Risk Stratification Markers: Applications to Public Health and Clinical Medicine — Invited Papers | ||
| Section on Statistics in Epidemiology , Biometrics Section , Health Policy Statistics Section , WNAR | ||
| Organizer(s): Estelle Russek-Cohen, FDA | ||
| Chair(s): Ruth Pfeiffer, National Cancer Institute | ||
| 8:35 AM | Risk Models for Deciding Whether to Take Tamoxifen to Prevent Breast Cancer and for Allocating Public Health Resources — Mitchell H. Gail, National Cancer Institute | |
| 9:00 AM | Risk Stratification Markers in Clinical Practice: An FDA Perspective — Estelle Russek-Cohen, FDA | |
| 9:25 AM | Using Cardiovascular Disease Risk Functions in Public Health and Clinical Trial: The Framingham Study Experience — Ralph B. D'Agostino, Sr., Boston University | |
| 9:50 AM | Discussant: Margaret Sullivan Pepe, Fred Hutchinson Cancer Research Center | |
| 10:10 AM | Floor Discussion | |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.